Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marganit Farago

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Cellular Signalling|October 27, 2019
Vav1 mutations: What makes them oncogenic?Marganit Farago, Tali Yarnitzky, Batel Shalom, et al.
Oncogenesis|October 10, 2018
Vav1 mutations identified in human cancers give rise to different oncogenic phenotypesBatel Shalom, Marganit Farago, Eli Pikarsky, et al.
Molecular Biology of the Cell|July 15, 2003
Rpb4p, a subunit of RNA polymerase II, mediates mRNA export during stressMarganit Farago, Tal Nahari, Christopher Hammel, et al.
Life Science Alliance|April 12, 2020
Vav1 and mutant K-Ras synergize in the early development of pancreatic ductal adenocarcinoma in miceYaser Salaymeh, Marganit Farago, Shulamit Sebban, et al.
Cells|March 25, 2022
Vav1 Promotes B-Cell Lymphoma DevelopmentBatel Shalom, Marganit Farago, Yaser Salaymeh, et al.
The Journal of Biological Chemistry|May 12, 2010
Tyrosine residues at the carboxyl terminus of Vav1 play an important role in regulation of its biological activityGalit Lazer, Liron Pe'er, Marganit Farago, et al.
FEBS Letters|November 28, 2009
Direct proteasome binding and subsequent degradation of unspliced XBP-1 prevent its intracellular aggregationAmi Navon, Ariel Gatushkin, Lior Zelcbuch, et al.
Cellular Signalling|June 25, 2022
Vav1 accelerates Ras-driven lung cancer and modulates its tumor microenvironmentBatel Shalom, Marganit Farago, Yaser Salaymeh, et al.
Molecular and Cellular Biochemistry|December 14, 2005
CK2 as a positive regulator of Wnt signalling and tumourigenesisDavid C Seldin, Esther Landesman-Bollag, Marganit Farago, et al.
Cancer Research|October 18, 2002
Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cellsCyril J Cohen, Noa Hoffmann, Marganit Farago, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Cellular Signalling|October 27, 2019
Vav1 mutations: What makes them oncogenic?Marganit Farago, Tali Yarnitzky, Batel Shalom, et al.
Oncogenesis|October 10, 2018
Vav1 mutations identified in human cancers give rise to different oncogenic phenotypesBatel Shalom, Marganit Farago, Eli Pikarsky, et al.
Molecular Biology of the Cell|July 15, 2003
Rpb4p, a subunit of RNA polymerase II, mediates mRNA export during stressMarganit Farago, Tal Nahari, Christopher Hammel, et al.
Life Science Alliance|April 12, 2020
Vav1 and mutant K-Ras synergize in the early development of pancreatic ductal adenocarcinoma in miceYaser Salaymeh, Marganit Farago, Shulamit Sebban, et al.
Cells|March 25, 2022
Vav1 Promotes B-Cell Lymphoma DevelopmentBatel Shalom, Marganit Farago, Yaser Salaymeh, et al.
The Journal of Biological Chemistry|May 12, 2010
Tyrosine residues at the carboxyl terminus of Vav1 play an important role in regulation of its biological activityGalit Lazer, Liron Pe'er, Marganit Farago, et al.
FEBS Letters|November 28, 2009
Direct proteasome binding and subsequent degradation of unspliced XBP-1 prevent its intracellular aggregationAmi Navon, Ariel Gatushkin, Lior Zelcbuch, et al.
Cellular Signalling|June 25, 2022
Vav1 accelerates Ras-driven lung cancer and modulates its tumor microenvironmentBatel Shalom, Marganit Farago, Yaser Salaymeh, et al.
Molecular and Cellular Biochemistry|December 14, 2005
CK2 as a positive regulator of Wnt signalling and tumourigenesisDavid C Seldin, Esther Landesman-Bollag, Marganit Farago, et al.
Cancer Research|October 18, 2002
Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cellsCyril J Cohen, Noa Hoffmann, Marganit Farago, et al.
Pageof 3